BiotechTube
Home/Bsense Bio Therapeutics/Dori Pelled, PhD
DP

Dori Pelled, PhD

Chief Executive Officer

Bsense Bio Therapeutics

Therapeutic Areas

PainTinnitusPruritus

Bsense Bio Therapeutics Pipeline

DrugIndicationPhase
BSEN760Chronic PainPhase 1
BSEN761TinnitusPreclinical
BSEN762PruritusPreclinical

Leadership Team at Bsense Bio Therapeutics

ST
Shmuel Tuvia, PhD
Chief Development Officer
View full Bsense Bio Therapeutics profile